Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
Jacopo Parizzi, Non-Malignant Haematology and Nephro-Rheumatology Unit Head at Roche, shared on LinkedIn:
”Looking toward 2027 with a clear vision and an unwavering commitment to patients!
The Roche Italy Non-Malignant Hematology team recently spent two intense and inspiring days together.
Our goal? To map out our strategy and design our commitment for 2027, ensuring we continue to pioneer solutions that truly matter.
Every discussion, brainstorm, and plan we created was driven by a single, powerful mission: to make a meaningful difference in the lives of patients living with Hemophilia A and Paroxysmal Nocturnal Hemoglobinuria (PNH).
By looking ahead and working together, we transform our dedication into concrete impact for the healthcare community and the people who inspire our work every day.
Proud of this passionate team and incredibly excited for the future we are building together!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
-
Aug 13, 2026, 08:11Cristiana Coneru: How the Gut Microbiome Influences Venous Thrombosis
-
Aug 13, 2026, 06:36Steffen Uffenorde: Improving Access to Automated Red Cell Exchange in SCD